This event will explore the issues encountered in eye drop development with relevance to basic scientists and clinicians, and will provide updates on novel AMD treatments and developments.
The eye is unique in that it is an organ that lends itself to local (topical) treatment. However, there are barriers to developing a successful formulation, with good safety and tolerability profile and maximal effectivity. Experts will discuss the potential pitfalls and challenges of eye drop development in ophthalmology, addressing CMC, regulatory and clinical issues. Invited speakers are experts in their field with experience of translating their formulations and research to the clinic.
Topics include:
This meeting has an optional 3-course chef's choice evening dinner. Please choose this option when booking to attend the dinner.
Can't make it to London for this event?
You can now live stream this meeting from anywhere. All's you need is a good internet connection. Click here to book the live stream.
There are bursary places available for all Ophthalmology meetings - send your request to ophthalmology@rsm.ac.uk
The Ophthalmology Section would like to thank Bausch + Lomb and Johnson & Johnson for supporting the Academic Year 2019-2020 Programme of Events
Please note that none of the companies listed have had any influence or involvement over the agenda, content or organisation of this meeting.
Research Professor at the Strathclyde Institute of Pharmacy and Biomedical Sciences.
Professor Wilson has an interest in oral and ocular delivery but has also worked on pulmonary and parenteral delivery systems. Current group spans biopharmaceutics, bioengineering and polymer synthesis.
Honorary Visiting Professor and Professor and Head of Optometry at the University of Plymouth.
Professor Christine Purslow started her career in hospital optometry, after which a variety of clinical roles followed including private practice, part-time teaching, and specialist contact lens practice. Chris was awarded her PhD from Aston University in 2005 (on Ocular Thermography), and went on to become a Senior Lecturer and Director of Postgraduate Taught Courses within WOPEC (Wales Optometry Postgraduate Education Centre), based at Cardiff University, as well as Director of the Contact Lens & Anterior Eye Research Unit (CLAER). Her most recent academic post was Professor and Head of Optometry at Plymouth University. In 2013, she was appointed to her current role as Head of Medical Affairs for Thea Pharmaceuticals (UK & Ireland), alongside research at Cardiff University, and visiting Professor at Plymouth, Cardiff and Aston. Chris has authored numerous scientific papers and professional articles, and presents regularly to both national and international audiences, generally on dry eye, tear film, ocular surface and contact lenses.
Professor M Francesca Cordeiro, Professor of Ophthalmology, Imperial College London
Professor Clive Wilson, Research Professor, University of Strathclyde
Professor Christine Purslow, Head of Medical Affairs, Thea Pharmaceuticals
Professor David Bates, Director, Cancer for Cancer Sciences and Head of Division of Cancer and Stem Cells, Nottingham University
Professor M Francesca Cordeiro
Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom
This meeting will update attendees on the current management of haemangiomas in children, ptosis surgery in children and the strabismus complications of lid surgery.
Improve your knowledge of normal paediatric development, paediatric eye conditions and emergencies, and equip yourself with the skills to examine children on the ward, out-of-hours, or in low resource settings.
This evening meeting will cover all aspects of ocular surface surgery for the general ophthalmologists. Fundamental areas such as the principles of surgery to the ocular surface, techniques to remove tissue, control healing, and altering the properties of tissues in the management of ocular surface conditions will be covered in detail by experts in the field.
This live stream event will explore the issues encountered in eye drop development with relevance to basic scientists and clinicians, and will provide updates on novel AMD treatments and developments.
